A cross-sectional international study found that women with autoimmune disease are more likely to have longer delays to diagnosis and to have misdiagnoses.

Profound advances in breast cancer testing have been made since testing first began in 1996. (HealthDay News) — Women who had genetic testing for inherited cancer risk years ago may want to ask about ...

An observational study suggests benefit from glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in end-stage kidney disease (ESKD).

A study showed that certain pregnancy complications are associated with an increased risk for cardiometabolic-renal conditions in subsequent years.

A meta-analysis of randomized trials supports intensive blood pressure lowering in chronic kidney disease (CKD) not on dialysis.

Patients with intermediate-risk prostate cancer who can safely forgo androgen deprivation therapy (ADT) may be spared its quality-of-life effects.

Study showed that the rates of sustained tobacco abstinence are higher with financial incentives vs usual care.

Two multinational cross-sectional studies revealed nail disorders and hair and scalp changes occur frequently among GLP-1 RA users.

A study showed that personalized support significantly increases likelihood that first-degree relatives of patients with hereditary cancers complete genetic testing.